Journal ArticleDOI
The role of 18F-FDG-PET/ceCT in peritoneal mesothelioma.
Julien Dubreuil,Francesco Giammarile,Pascal Rousset,Domenico Rubello,Naoual Bakrin,Guillaume Passot,Sylvie Isaac,Olivier Glehen,Andrea Skanjeti +8 more
Reads0
Chats0
TLDR
Although multicentre prospective studies are necessary, 18F-FDG-PET/ceCT appears to be a promising tool in patients affected by peritoneal mesothelioma, whereas SUVmaxlesion was associated with PFS in the latter.Abstract:
PurposeThe aim of this study was to assess glucose metabolism of multicystic peritoneal mesothelioma and epithelioid peritoneal mesothelioma by fluorine-18 fluorodeoxyglucose (18F-FDG)-PET/contrast-enhanced computed tomography (ceCT) and to assess its prognostic impact.Materials and methodsTwenty-thread more
Citations
More filters
Journal ArticleDOI
Peritoneal mesothelioma: PSOGI/EURACAN clinical practice guidelines for diagnosis, treatment and follow-up.
TL;DR: In this paper, a steering committee for standardizing diagnosis and management of peritoneal mesothelioma (PM) is established, which is a rare and aggressive malignancy characterized by widespread multiple metastatic tumour nodules originating from the peritoneum.
Journal ArticleDOI
Can [18F]F-FDG PET/CT be used to assess the pre-operative extent of peritoneal carcinomatosis in patients with colorectal cancer?
Fortuné M.K. Elekonawo,Bas Starremans,Sander Thomas Laurens,Andreas J A Bremers,Johannes H. W. de Wilt,Linda Heijmen,Lioe-Fee de Geus-Oei,Lioe-Fee de Geus-Oei +7 more
TL;DR: PET/CT underestimates the extent of PC during surgery in both mucinous and non-mucinous CRC and is not recommended for intraperitoneal tumor scoring.
Journal ArticleDOI
Multicystic and diffuse malignant peritoneal mesothelioma in children
Sophie Vermersch,Alexis Arnaud,Daniel Orbach,Nicolas André,Claire Berger,Vahan Kepenekian,Cécile Brigand,Brice Fresneau,Marie‐Laurence Poli‐Merol,Cyril Habougit,François Varlet,Aurélien Scalabre +11 more
TL;DR: Malignant and multicystic peritoneal mesotheliomas are extremely rare tumors in children, developing from mesothelial cells.
Journal ArticleDOI
PET/CT Variants and Pitfalls in Gynecological Cancers.
TL;DR: The role of hybrid imaging with 2-[18F] flourodeoxyglucose (FDG) positron emission tomography and computed tomography (PET/CT) is continuously evolving and now considered standard practice in evaluation of disease stage, treatment response, recurrent disease and follow-up for numerous primary malignancies as mentioned in this paper.
Journal ArticleDOI
Focal Peritoneal Mesothelioma Demonstrated on FDG PET/CT.
TL;DR: A 48-year-old woman was experiencing abdominal pain and melena for 3 months, and an FDG PET/CT was performed to assess occult tumor, which demonstrated low-grade epithelioid peritoneal mesothelioma.
References
More filters
Book ChapterDOI
Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis
TL;DR: Objective response criteria from CT scan, tumor marker, and radiolabeled monoclonal antibody studies are necessary in a regular follow-up schedule.
Journal ArticleDOI
Dangers of using "optimal" cutpoints in the evaluation of prognostic factors.
Journal ArticleDOI
FDG PET evaluation of mucinous neoplasms: correlation of FDG uptake with histopathologic features.
TL;DR: FDG PET is limited in the evaluation of mucinous tumors, particularly in hypocellular lesions with abundant mucin, and two histologic features were found to be predictive of FDG PET results: tumor cellularity and the amount of mucin.
Journal ArticleDOI
From the archives of the AFIP: primary peritoneal tumors: imaging features with pathologic correlation.
TL;DR: This unusual group of tumors is linked together by a common site of origin and imaging manifestations that mimic those of peritoneal carcinomatosis, and knowledge of the spectrum of imaging findings in this group of primaryPeritoneal tumors, along with their clinical and pathologic characteristics, is important in the evaluation of patients with diffuse peritoneAL disease.
Journal ArticleDOI
The Warburg effect in 2012.
Jean-Pierre Bayley,Peter Devilee +1 more
TL;DR: The results discussed illustrate the growing integration of the previously distinct fields of molecular biological and metabolic cancer research and show that this synergy is beginning to yield a more complete and comprehensive understanding of the tumor cell.